ZetaBio Group took part in BioSTART 2025, the biotechnology entrepreneurship competition organised by BioInnovation Greece. The main event took place on 18 September 2025 at the Bio3 Forum, Technopolis, Athens.
ZetaBio presented its work to the evaluators. The talk started from a simple problem: most oncology drugs that look promising in the lab fail in clinical trials, largely because 2D cultures and animal models do not predict how human tumours respond. It then outlined our approach, human-relevant 3D cancer models for drug testing, and the stages we plan to take it through, from model development to validation.
